Search

Author/Creator Ginman, Claes

1. 2-weekly versus 3-weekly docetaxel for metastatic castration-resistant prostate cancer: complete quality of life results from the randomised, phase-III PROSTY trial. (3rd August 2022)

Authors:
Lehtonen, Miikka; Sormunen, Jorma; Luukkaala, Tiina; Marttila, Timo; McDermott, Ray; Joensuu, Timo; Lehtinen, Ilari; Ginman, Claes; Kellokumpu-Lehtinen, Pirkko-Liisa
Journal:
Acta oncologica
Issue:
Volume 61:Number 8(2022)
Page Start:
963
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial. Issue 2 (February 2021)

Authors:
Fransson, Per; Nilsson, Per; Gunnlaugsson, Adalsteinn; Beckman, Lars; Tavelin, Björn; Norman, David; Thellenberg-Karlsson, Camilla; Hoyer, Morten; Lagerlund, Magnus; Kindblom, Jon; Ginman, Claes; Johansson, Bengt; Björnlinger, Kirsten; Seke, Mihajl; Agrup, Måns; Zackrisson, Björn; Kjellén, Elisab...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 2(2021)
Page Start:
235
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search